FTSE All-Share
5.640,43
PKT
-139,82
PKT
-2,42
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.02.15 | Rio Tinto Outperform | BNP PARIBAS | |
| 13.02.15 | Rio Tinto buy | Deutsche Bank AG | |
| 13.02.15 | Glencore Hold | S&P Capital IQ | |
| 13.02.15 | Rio Tinto overweight | HSBC | |
| 13.02.15 | Rio Tinto buy | UBS AG | |
| 13.02.15 | GSK overweight | Barclays Capital | |
| 13.02.15 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 13.02.15 | GSK buy | UBS AG | |
| 12.02.15 | Rio Tinto Hold | S&P Capital IQ | |
| 12.02.15 | Glencore kaufen | Independent Research GmbH | |
| 12.02.15 | Glencore Underweight | JP Morgan Chase & Co. | |
| 12.02.15 | Sky Neutral | Goldman Sachs Group Inc. | |
| 12.02.15 | Glencore Neutral | UBS AG | |
| 12.02.15 | Shell (ex Royal Dutch Shell) buy | Société Générale Group S.A. (SG) | |
| 12.02.15 | BP Hold | Société Générale Group S.A. (SG) | |
| 12.02.15 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 12.02.15 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 12.02.15 | Diageo Sell | Goldman Sachs Group Inc. | |
| 11.02.15 | Glencore Neutral | Goldman Sachs Group Inc. | |
| 11.02.15 | Rio Tinto Sell | Goldman Sachs Group Inc. | |
| 11.02.15 | Glencore Reduce | Nomura | |
| 11.02.15 | BP Neutral | UBS AG | |
| 10.02.15 | BT Group buy | Nomura | |
| 10.02.15 | Barclays overweight | Morgan Stanley | |
| 10.02.15 | AstraZeneca verkaufen | Barclays Capital | |
| 10.02.15 | Rio Tinto buy | UBS AG | |
| 10.02.15 | GSK verkaufen | JP Morgan Chase & Co. | |
| 09.02.15 | GSK Halten | Independent Research GmbH | |
| 09.02.15 | BT Group buy | Jefferies & Company Inc. | |
| 09.02.15 | Vodafone Group Halten | Independent Research GmbH | |
| 09.02.15 | AstraZeneca buy | UBS AG | |
| 09.02.15 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 09.02.15 | Unilever Outperform | Bernstein Research | |
| 09.02.15 | Unilever Outperform | Bernstein Research | |
| 06.02.15 | Vodafone Group overweight | JP Morgan Chase & Co. | |
| 06.02.15 | Vodafone Group buy | Citigroup Corp. | |
| 06.02.15 | Vodafone Group overweight | Morgan Stanley | |
| 06.02.15 | Prudential Neutral | JP Morgan Chase & Co. | |
| 06.02.15 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 06.02.15 | Vodafone Group buy | Goldman Sachs Group Inc. |